|
|
|
Volumn 20, Issue 4, 2007, Pages 271-278
|
|
The latest advances in kidney diseases and related disorders
a
a
HOSPITAL CLÍNIC
(Spain)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AFFYMAX;
ANGIOTENSIN 1 RECEPTOR ANTAGONIST;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCINEURIN INHIBITOR;
CALCIUM CHANNEL BLOCKING AGENT;
CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR;
CORTICOSTEROID;
CYCLOSPORIN;
CYCLOSPORIN A;
DACLIZUMAB;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ERYTHROPOIETIN;
HEMATIDE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
PHOSPHATE BINDING AGENT;
RAPAMYCIN;
RECOMBINANT ERYTHROPOIETIN;
TACROLIMUS;
UNCLASSIFIED DRUG;
VALSARTAN;
VITAMIN D DERIVATIVE;
ANEMIA;
ARTERIOVENOUS FISTULA;
ARTERY DISEASE;
BLOOD TRANSFUSION;
CHRONIC KIDNEY DISEASE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
DIABETIC NEPHROPATHY;
DIARRHEA;
DISEASE ASSOCIATION;
DIZZINESS;
DRUG DESIGN;
DRUG DOSE COMPARISON;
DRUG DOSE TITRATION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG MEGADOSE;
DRUG RESPONSE;
DRUG SAFETY;
DRUG WITHDRAWAL;
GRAFT REJECTION;
HEADACHE;
HEART FAILURE;
HEMODIALYSIS PATIENT;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
HYPERKALEMIA;
HYPERTENSION;
HYPOTENSION;
INJECTION SITE REACTION;
KIDNEY DISEASE;
KIDNEY TRANSPLANTATION;
LOW DRUG DOSE;
METABOLIC DISORDER;
MINERAL METABOLISM;
MORBIDITY;
PERIPHERAL EDEMA;
QUALITY OF LIFE;
RANDOMIZED CONTROLLED TRIAL;
RENAL REPLACEMENT THERAPY;
RHINOPHARYNGITIS;
THROMBOSIS;
ANEMIA;
ANIMALS;
ERYTHROPOIETIN;
HUMANS;
KIDNEY DISEASES;
KIDNEY TRANSPLANTATION;
RENAL DIALYSIS;
TREATMENT OUTCOME;
|
|
EID: 34547733023
PISSN: 02140934
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (9)
|
|
References (1)
|
